Pfizer Limited announced the appointment of Mr. Nilesh Pendse as Category Lead ? Vaccines of the Company with effect from February 1, 2026. Mr. Pendse shall accordingly be a Senior Management Personnel of the company effective the said date.
Mr. Pendse joined Pfizer Products India Private Limited in 2024, where he led the Oncology Business, focusing on strategic growth, market access, and stakeholder engagement to advance cancer care. Prior to joining Pfizer Products India Private Limited, Mr. Pendse held leadership roles at Boehringer Ingelheim and Novartis where he managed diabetes and neurosciences Divisions, with a focus on sales, marketing, and franchise operations. In addition, Mr. Pendse comes from consulting background experience with firms such as Boston Consulting Group, Ernst & Young (EY) and Accenture, where he led projects related to strategy, revenue acceleration, and business transformation.
Mr. Nilesh Pendse holds an MBA in Marketing from Jamnalal Bajaj Institute of Management Studies and a Bachelor?s degree in Electronics Engineering from the University of Mumbai. The company also announced that Mr. Manikantan Seshadrinathan ? Category Lead, Hospitals & Rare Disease will transition to another role within the Pfizer Group Companies effective February 1, 2026, and shall accordingly cease to be a Senior Management Personnel of the Company effective January 31, 2026.
Mr. Prashant Mahalingam, Category Lead ? Internal Medicine, will take up additional responsibility of the Hospitals Business of the Company and shall be redesignated as Category Lead ? Internal Medicine & Hospitals, effective February 1, 2026.
